SAB Biotherapeutics Appoints Katie Ellias to the Board of Directors

SIOUX FALLS, S.D., Nov. 20, 2023 -- SAB Biotherapeutics , a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing a fully-human anti-thymocyte...

Related Keywords

Paris ,France General ,France ,Geneva ,Genè ,Switzerland ,Katie Ellias ,Samuelj Reich ,Biotherapeutics Inc ,Medtronic ,International Relations ,Mckinsey Company ,University Of Pennsylvania ,Company Board Of Directors ,Rd Fund ,Exchange Commission ,Wharton School ,Managing Director ,Veralox Therapeutics ,Endeavour Vision ,Sofinnova Partners ,Healthcare Management ,Political Science ,Executive Chairman ,Private Securities Litigation Reform Act ,Markets ,